Taj Pharma is one of the leading generic pharmaceutical company in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. We have eight manufacturing sites under flagship in India to support our market standing. Today, we market more than 100+ branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.
Today, we market more than 100+ branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.
At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its numerous and wide-ranging issues – from complex research, development and regulatory conditions to rapidly changing consumer demands.
Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.
We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian countries.
Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.
Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the launched markets.
We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian countries.
Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.
Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the launched markets.
We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian countries.
Please click here to see full Prescribing Information for Trientine hydrochloride Capsules.
“Treatment of patients with Trientine Hydrochloride Capsules may be complicated by severe, sometimes lifethreatening, adverse effects. Trientine Hydrochloride Capsules should be administered under the supervision of a physician experienced in the use of this medication for the treatment of sickle cell anemia.”
“Hydroxyurea is mutagenic and clastogenic, and causes cellular transformation to a tumorigenic phenotype. Hydroxyurea is thus unequivocally genotoxic and a presumed transspecies carcinogen which implies a carcinogenic risk to humans. In patients receiving long-term hydroxyurea for myeloproliferative disorders, such as polycythemia vera and thrombocythemia, secondary leukaemia’s have been reported. It is unknown whether this leukemogenic effect is secondary to hydroxyurea or is associated with the patient's underlying disease. The physician and patient must very carefully consider the potential benefits of Trientine Hydrochloride Capsules relative to the undefined risk of developing secondary malignancies. Trientine Hydrochloride Capsules is used to treat chronic myeloid leukaemia or cervical cancer.”
“Your medical team will discuss with you the options for treating your cancer. They will take into account factors such as the type of cancer, where it is, which stage it is at and whether you have had treatment before. The results of blood tests and other investigations will also be considered. How well you feel and how you are likely to cope with treatment is also important.”
“Your cancer treatment will usually consist of a treatment session with Trientine Hydrochloride Capsules followed by a break of a number of days before the next treatment session with Trientine Hydrochloride Capsules. This cycle may be repeated many times as part of your cancer treatment. Trientine Hydrochloride Capsules works by damaging cancer cells in the body. Trientine Hydrochloride Capsules also affects healthy cells and treatment with Trientine Hydrochloride Capsules may damage your immune system. Your medical team may arrange for you to have some blood tests to check how well your immune system is working. Do not share your medicine with other people. It may not be suitable for them and may harm them. The pharmacy label on your medicine tells you how much medicine you should take. It also tells you how often you should take your medicine. This is the dose that you and your prescriber have agreed you should take. You should not change the dose of your medicine unless you are told to do so by your prescriber. If you feel that the medicine is making you unwell or you do not think it is working, then talk to your prescriber.
